CD8+ T细胞通过调解腺A2A受体和谷氨/GPX4之间交叉反应来维持抗瘤反应
Siqi Chen1, Jie Fan1, Ping Xie1
1Department of Medicine, Hematology/Oncology Division, Robert H. Lurie Comprehensive Cancer Center.
The Journal of clinical investigation
|March 5, 2024
概括
向腺A2A受体 (A2AR) 信号传递和谷氨酸 (GSH) /谷氨酸过氧化酶4 (GPX4) 途径可以提高CD8+T细胞适合采用细胞疗法. 这种方法可以防止铁亡,改善抗瘤反应和患者的存活率.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
- 癌症生物学 癌症生物学
背景情况:
- CD8+ T 细胞的抗瘤反应取决于代谢适应性.
- 瘤中的高谷氨 (GSH) 水平通过抑制铁灭促进癌症的进展和治疗耐药性.
- 谷氨过氧化酶4 (GPX4) 依赖性铁亡是癌细胞死亡的关键机制.
研究的目的:
- 调查腺A2A受体 (A2AR) 信号传导和GSH/GPX4轴在CD8+T细胞代谢适应性和生存中的作用.
- 在癌症免疫治疗中探索增强CD8+T细胞功能的治疗策略.
- 确定与癌症患者临床反应相关的生物标志物.
主要方法:
- 用A2AR抑制剂和脂质过氧化阻断剂对激活的CD8+T细胞进行体外治疗.
- 在体内评估CD8+T细胞增殖,持久性和ferroptosis预防.
- 在人类癌症队列中,对内CD8+T细胞进行与GSH代谢 (GMGS) 相关的基因特征的分析.
主要成果:
- 同时抑制A2AR和脂质过氧化显著增强了CD8+T细胞的增殖和持久性.
- 这种联合抑制阻止了激活的CD8+T细胞中的铁亡.
- 内CD8+T细胞中GSH代谢的特定基因特征 (GMGS) 与多种癌症中改善的临床反应和生存相关.
结论:
- A2AR信号传递和GSH/GPX4轴是CD8+T细胞代谢适应性和抗瘤功能的关键调节者.
- 联合抑制A2AR和脂质过氧化是一种有前途的策略,通过预防T细胞铁亡来增强采用细胞疗法.
- 鉴定到的GMGS可以作为癌症患者免疫治疗反应的预测生物标志物.
更多相关视频
相关概念视频
Cytotoxic T Cells-mediated Immune Response
908
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
908
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
T Cell Activation and Clonal Selection
731
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
731


